Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

statnews.com

STAT

Get the latest updates from STAT directly as they happen.

Follow now 208 followers

Latest posts

Last updated about 4 hours ago

Opinion: ER docs are too quick to assume cannabis users are experiencing this rare side effect

about 4 hours ago

Human health is complex and diagnostic tools and their limitations, so missing...

Opinion: I work in drug law enforcement and policy. Maybe pharma companies should develop ‘safe’ recreational drugs

about 4 hours ago

Like many adolescents, I struggled mightily with oily skin, large pores, and...

STAT+: How Republicans sidelined the health care industry and pushed through historic Medicaid cuts

about 4 hours ago

WASHINGTON — Republicans swiftly approved President Trump’s tax cut bill last week...

Male and female athletes have different hearts, and that can have serious consequences

about 4 hours ago

The naked chest of a female mannequin brought home the cardiologist’s point...

Leading medical groups sue Kennedy over changed Covid-19 vaccine recommendations

about 19 hours ago

WASHINGTON — Six major medical groups, and a pregnant physician, are suing...

STAT+: Survival rates for cancer patients on immunotherapy depend on insurance coverage

about 21 hours ago

As a cancer patient, access to innovative drugs can help extend your...

STAT+: Cogent Biosciences drug improves symptoms of chronic immune disorder, study results show

about 22 hours ago

Cogent Biosciences said Monday that its experimental drug reduced the symptoms of...

STAT+: The impending uninsured surge from Trump’s tax-cut bill

about 22 hours ago

This is the online version of STAT’s weekly email newsletter Health Care...

STAT+: Khosla Ventures sets sights on $4 billion in new funds

about 23 hours ago

Want to stay on top of the science and politics driving biotech...

STAT+: Pharmalittle: We’re reading about FDA morale, a U.S.-Swiss trade deal on pharma levies, and more

about 24 hours ago

Good morning, everyone, and welcome to another working week. We hope the...

STAT+: Apogee reports first data on long-acting eczema drug

1 day ago

Apogee Therapeutics said Monday that its experimental antibody treatment alleviated the signs...

Opinion: Don’t let states interfere with medical school grading systems

1 day ago

A “quiet but consequential erosion of standards” is how a Republican Texas...